{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:39:03Z","timestamp":1756384743734,"version":"3.44.0"},"reference-count":23,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,11,18]]},"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>Multicentric Castleman disease is a rare polyclonal lymphoproliferative disorder mainly associated with two renal manifestations: thrombotic microangiopathy and amyloidosis. Nevertheless, we report here a case of human herpes virus-8 negative multicentric Castleman disease with membranous proliferative glomerulonephritis and extracapillary proliferation. A patient was successfully treated with corticosteroids, anti-CD20 and cyclophosphamide therapy.<\/jats:p>","DOI":"10.1136\/bcr-2019-231844","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T09:21:16Z","timestamp":1579598476000},"page":"e231844","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis"],"prefix":"10.1136","volume":"13","author":[{"given":"Maria Brito","family":"Nunes","sequence":"first","affiliation":[{"name":"Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Rotman","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois-Regis","family":"Duss","sequence":"additional","affiliation":[{"name":"Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Halfon","sequence":"additional","affiliation":[{"name":"Nephrology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"2025082709025582000_13.1.e231844.1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMcpc1610100","article-title":"Case 5-2017. A 19-year-old man with hematuria and a retroperitoneal mass.","volume":"376","author":"Blute","year":"2017","journal-title":"N Engl J Med"},{"key":"2025082709025582000_13.1.e231844.2","first-page":"2407","article-title":"A retrospective study of 34 patients with unicentric and multicentric Castleman\u2019s disease: experience from a single institution","volume":"15","author":"Jiang","year":"2018","journal-title":"Oncol Lett"},{"key":"2025082709025582000_13.1.e231844.3","first-page":"486","article-title":"Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy","volume":"8","author":"van Rhee","year":"2010","journal-title":"Clin Adv Hematol Oncol"},{"key":"2025082709025582000_13.1.e231844.4","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15019"},{"key":"2025082709025582000_13.1.e231844.5","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1016\/S2352-3026(16)00007-7","article-title":"The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease research","volume":"3","author":"Fajgenbaum","year":"2016","journal-title":"The Lancet Haematology"},{"key":"2025082709025582000_13.1.e231844.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-746933"},{"key":"2025082709025582000_13.1.e231844.7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.hoc.2017.09.002","article-title":"Castleman disease pathogenesis","volume":"32","author":"Fajgenbaum","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"2025082709025582000_13.1.e231844.8","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/S2352-3026(16)00006-5","article-title":"Idiopathic multicentric Castleman's disease: a systematic literature review","volume":"3","author":"Liu","year":"2016","journal-title":"Lancet Haematol"},{"key":"2025082709025582000_13.1.e231844.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70319-5"},{"key":"2025082709025582000_13.1.e231844.10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23291"},{"key":"2025082709025582000_13.1.e231844.11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq427"},{"key":"2025082709025582000_13.1.e231844.12","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr245"},{"key":"2025082709025582000_13.1.e231844.13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2169\/internalmedicine.9556-17","article-title":"Nephrotic syndrome with thrombocytopenia, lymphadenopathy, systemic inflammation, and splenomegaly","volume":"57","author":"Nakamori","year":"2018","journal-title":"Intern. Med."},{"key":"2025082709025582000_13.1.e231844.14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10157-011-0499-9","article-title":"Renal complications of Castleman\u2019s disease: report of two cases and analysis of 75 cases","volume":"15","author":"Yuan","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"2025082709025582000_13.1.e231844.15","doi-asserted-by":"crossref","first-page":"e1.1","DOI":"10.1053\/j.ajkd.2003.09.023","article-title":"Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?","volume":"43","author":"Seida","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2025082709025582000_13.1.e231844.16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.humpath.2018.03.021","article-title":"Renal histology in a patient with TAFRO syndrome: a case report","volume":"82","author":"Mizuno","year":"2018","journal-title":"Hum Pathol"},{"key":"2025082709025582000_13.1.e231844.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4602"},{"key":"2025082709025582000_13.1.e231844.18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.hoc.2017.09.003","article-title":"The role of interleukin-6 in Castleman disease","volume":"32","author":"Yoshizaki","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"2025082709025582000_13.1.e231844.19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5414\/CN108621","article-title":"Report of six kidney disease-associated Castleman's disease cases","volume":"84","author":"Sui","year":"2015","journal-title":"Clin Nephrol"},{"key":"2025082709025582000_13.1.e231844.20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ajh.2830460306","article-title":"Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease","volume":"46","author":"Perfetti","year":"1994","journal-title":"Am J Hematol"},{"key":"2025082709025582000_13.1.e231844.21","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.50.11.965"},{"key":"2025082709025582000_13.1.e231844.22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-862334"},{"key":"2025082709025582000_13.1.e231844.23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-748855"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-231844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:03:02Z","timestamp":1756310582000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-231844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,6]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1136\/bcr-2019-231844"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-231844","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}